Abstract |
In a 9-week open-label study, 7 outpatients with obsessive compulsive disorder were treated with fluoxetine, a selective inhibitor of neuronal reuptake of serotonin. A significant improvement was found in the symptomatology of patients as measured on the obsessive compulsive subscale of the Comprehensive Psychopathological Rating Scale (p less than 0.001) and the Clinical Global Impression of severity of illness (p less than 0.01). These findings support the hypothesis that serotoninergic antidepressants may be useful in the treatment of obsessive compulsive disorder.
|
Authors | R Fontaine, G Chouinard |
Journal | Progress in neuro-psychopharmacology & biological psychiatry
(Prog Neuropsychopharmacol Biol Psychiatry)
Vol. 9
Issue 5-6
Pg. 605-8
( 1985)
ISSN: 0278-5846 [Print] England |
PMID | 3878975
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Adult
- Female
- Fluoxetine
(adverse effects, therapeutic use)
- Humans
- Male
- Middle Aged
- Obsessive-Compulsive Disorder
(drug therapy, psychology)
- Propylamines
(therapeutic use)
- Psychiatric Status Rating Scales
|